{"id":98396,"date":"2022-07-27T11:00:59","date_gmt":"2022-07-27T10:00:59","guid":{"rendered":"https:\/\/www.pbctoday.co.uk\/news\/?p=98396"},"modified":"2022-07-27T12:54:02","modified_gmt":"2022-07-27T11:54:02","slug":"manufacturing-innovation-centre","status":"publish","type":"post","link":"https:\/\/www.pbctoday.co.uk\/news\/planning-construction-news\/manufacturing-innovation-centre\/98396\/","title":{"rendered":"[Video] Medicines Manufacturing Innovation Centre nears completion"},"content":{"rendered":"

Tilbury Douglas releases final flyover footage of its Medicines Manufacturing Innovation Centre <\/span>(MMIC) in Scotland, as the project nears completion<\/span><\/h2>\n

The innovation centre, built by Tilbury Douglas<\/a>, will help solve major pharmaceutical industry challenges and accelerate access to affordable medicines.<\/p>\n

Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the \u00a335m facility will develop next-generation pharmaceutical manufacturing processes<\/a> to drive forward innovation<\/a> in the medicines supply chain.<\/p>\n

Pioneered through a public-private collaboration<\/h3>\n

The facility has been pioneered through a public-private collaboration between technology innovation organisation, CPI, the University of Strathclyde,\u00a0UK\u00a0Research and Innovation, Scottish Enterprise and founding industry partners, AstraZeneca and\u00a0GSK.<\/p>\n

Two-storey steel frame construction<\/h3>\n

The centre, a two-storey steel frame construction<\/a> on piled foundations<\/a>, includes an office and reception area plus GMP compliant facilities. This includes four ISO 8 pharmaceutical cleanrooms with associated materials and people airlocks as well as GMP compliant supporting activities including warehousing, process utilities, QC and analytical labs.<\/p>\n

In the first five years of its operation, the centre is expected to support over 100 jobs, both technical and non-technical, and generate \u00a3200M investment in advanced technologies<\/a>.<\/p>\n

International beacon in medicines manufacturing<\/h3>\n

The facility aims to become an international beacon in medicines manufacturing, driving international engagement and attracting firms that do not currently have a presence in the UK.<\/p>\n

Dave Tudor, managing director of the Medicines Manufacturing Innovation Centre at CPI, said: \u201cThe Medicines Manufacturing Innovation Centre will help the pharmaceutical industry to increase momentum in technology translation by creating partnerships, working with regulators and partnering with innovators.<\/p>\n

\u201cThis will ultimately lead to a reduction in time to market, drive productivity, improve compliance and reduce the carbon footprint of medicines manufacturing. We continue to collaborate with industry and academic partners to develop next-generation digital manufacturing technologies, bringing us closer to medicines innovation that will ultimately benefit patients.\u201d<\/p>\n

\n

Watch the final flyover #video<\/a> of our Medicines Manufacturing Innovation Centre in Renfrewshire.<\/p>\n

With the project nearing completion, we look forward to our client CPI officially opening MMIC later in the year.<\/p>\n

Watch it here: https:\/\/t.co\/JvjWODRcXo<\/a>#project<\/a> #construction<\/a><\/p>\n

\u2014 Tilbury Douglas (@Tilbury_douglas) July 21, 2022<\/a><\/p><\/blockquote>\n